Novo Nordisk
-
Stories
Ozempic, The Miracle Weight Loss Drug That Has Triggered Worldwide Debate, From Hollywood’s “Ozempic Epidemic” To Warnings “It Could Be The Next Opioid Crises” To “Fat Phobia”; How Ozempic Could Affect The Health Of The Global Economy In More Ways Than One!
Ozempic, a drug initially designed to treat type 2 diabetes, has unexpectedly become a global sensation. Much like Viagra's tremendous…
Read More » -
Trends
The Head of Novo Nordisk India Sets Sights on 2026 Launch of Wegovy Obesity Drug; The Growing Obesity Drug Market With A $200 Billion Potential
Novo Nordisk is gearing up to introduce its highly successful weight-loss medication, Wegovy, to the Indian market by 2026; the…
Read More » -
Trends
Novo Nordisk will lower insulin pricing in the U.S. after Eli Lilly.
Novo Nordisk will lower insulin pricing in the U.S. after Eli Lilly. Novo Nordisk has done the same, two weeks…
Read More »